~ Buy the VOQUEZNA TRIPLE PAK (amoxicillin; clarithromycin; vonoprazan fumarate) Drug Profile, 2024 PDF Report in the Report Store ~

VOQUEZNA TRIPLE PAK Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

When do Voquezna Triple Pak patents expire, and what generic alternatives are available?

Voquezna Triple Pak is a drug marketed by Phathom and is included in one NDA. There are two patents protecting this drug.

This drug has one hundred and three patent family members in forty-three countries.

The generic ingredient in VOQUEZNA TRIPLE PAK is amoxicillin; clarithromycin; vonoprazan fumarate. There are forty-six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amoxicillin; clarithromycin; vonoprazan fumarate profile page.

DrugPatentWatch^® Generic Entry Outlook for Voquezna Triple Pak

Voquezna Triple Pak will be eligible for patent challenges on May 3, 2026. This date may extended up to six months if a pediatric exclusivity extension is applied to the drug's patents.

By analyzing the patents and regulatory protections it appears that the earliest date for generic entry will be May 3, 2032. This may change due to patent challenges or generic licensing.

Indicators of Generic Entry

< Available with Subscription >

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for VOQUEZNA TRIPLE PAK?
What are the global sales for VOQUEZNA TRIPLE PAK?
What is Average Wholesale Price for VOQUEZNA TRIPLE PAK?

Summary for VOQUEZNA TRIPLE PAK

International Patents:	103
US Patents:	2
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Drug Prices:	Drug price information for VOQUEZNA TRIPLE PAK
DailyMed Link:	VOQUEZNA TRIPLE PAK at DailyMed

Drug patent expirations by year for VOQUEZNA TRIPLE PAK

DrugPatentWatch^® Estimated Loss of Exclusivity (LOE) Date for VOQUEZNA TRIPLE PAK

Generic Entry Date for VOQUEZNA TRIPLE PAK^: ⤷ Sign Up* Constraining patent/regulatory exclusivity: GENERATING ANTIBIOTIC INCENTIVES NOW NDA: 215152 Dosage: CAPSULE, TABLET, TABLET;ORAL

^*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

US Patents and Regulatory Information for VOQUEZNA TRIPLE PAK

VOQUEZNA TRIPLE PAK is protected by two US patents and two FDA Regulatory Exclusivities.

Based on analysis by DrugPatentWatch, the earliest date for a generic version of VOQUEZNA TRIPLE PAK is ⤷ Sign Up.

This potential generic entry date is based on GENERATING ANTIBIOTIC INCENTIVES NOW.
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.

Patents protecting VOQUEZNA TRIPLE PAK

1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Pharmaceutical composition
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

FDA Regulatory Exclusivity protecting VOQUEZNA TRIPLE PAK

NEW CHEMICAL ENTITY
Exclusivity Expiration: ⤷ Sign Up

GENERATING ANTIBIOTIC INCENTIVES NOW
Exclusivity Expiration: ⤷ Sign Up

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Phathom	VOQUEZNA TRIPLE PAK	amoxicillin; clarithromycin; vonoprazan fumarate	CAPSULE, TABLET, TABLET;ORAL	215152-001	May 3, 2022		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up		Y		⤷ Sign Up
Phathom	VOQUEZNA TRIPLE PAK	amoxicillin; clarithromycin; vonoprazan fumarate	CAPSULE, TABLET, TABLET;ORAL	215152-001	May 3, 2022		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Phathom	VOQUEZNA TRIPLE PAK	amoxicillin; clarithromycin; vonoprazan fumarate	CAPSULE, TABLET, TABLET;ORAL	215152-001	May 3, 2022		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for VOQUEZNA TRIPLE PAK

When does loss-of-exclusivity occur for VOQUEZNA TRIPLE PAK?

Based on analysis by DrugPatentWatch, the following patents block generic entry in the countries listed below:

Argentina

Patent: 2842
Patent: COMPOSICION FARMACEUTICA ESTABILIZADA QUE COMPRENDE UN INGREDIENTE FARMACEUTICAMENTE ACTIVO NO PEPTIDICO
Estimated Expiration: ⤷ Sign Up

Australia

Patent: 09277443
Patent: Pharmaceutical composition
Estimated Expiration: ⤷ Sign Up

Brazil

Patent: 0916689
Patent: composição farmacêutica estabilizada, preparação sólida, e, métodos para estabilizar uma composição farmacêutica, e para estabilizar uma preparação sólida.
Estimated Expiration: ⤷ Sign Up

Canada

Patent: 32243
Patent: COMPOSITION PHARMACEUTIQUE (PHARMACEUTICAL COMPOSITION)
Estimated Expiration: ⤷ Sign Up

Patent: 36400
Patent: COMPOSITION PHARMACEUTIQUE (PHARMACEUTICAL COMPOSITION)
Estimated Expiration: ⤷ Sign Up

Chile

Patent: 11000170
Patent: Composicion farmaceutica solida y estabilizada que comprende un ingrediente farmaceuticamente activo, oxido de titanio y un plastificante; procedimiento para estabilizar la composicion farmaceutica durante una irradiacion luminosa.
Estimated Expiration: ⤷ Sign Up

Patent: 13000224
Patent: Preparacion solida mejorada que comprende un ingrediente farmaceuticamente activo, un plastificante y un acido organico de cadena; metodo para estabilizar una preparacion solida (divisional sol 170-11)
Estimated Expiration: ⤷ Sign Up

China

Patent: 2164581
Patent: Pharmaceutical composition
Estimated Expiration: ⤷ Sign Up

Patent: 2743330
Patent: Pharmaceutical composition
Estimated Expiration: ⤷ Sign Up

Patent: 4784180
Patent: Pharmaceutical composition
Estimated Expiration: ⤷ Sign Up

Colombia

Patent: 90638
Patent: COMPOSICIÓN FARMACÉUTICA
Estimated Expiration: ⤷ Sign Up

Costa Rica

Patent: 110110
Patent: COMPOSICION FARMACEUTICA
Estimated Expiration: ⤷ Sign Up

Dominican Republic

Patent: 011000033
Patent: COMPOSICION FARMACEUTICA
Estimated Expiration: ⤷ Sign Up

Patent: 013000172
Patent: COMPOSICION FARMACEUTICA
Estimated Expiration: ⤷ Sign Up

Ecuador

Patent: 11010855
Patent: COMPOSICIÓN FARMACÉUTICA
Estimated Expiration: ⤷ Sign Up

Eurasian Patent Organization

Patent: 1170272
Patent: ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ
Estimated Expiration: ⤷ Sign Up

Patent: 1201451
Patent: ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ
Estimated Expiration: ⤷ Sign Up

European Patent Office

Patent: 09985
Patent: COMPOSITION PHARMACEUTIQUE (PHARMACEUTICAL COMPOSITION)
Estimated Expiration: ⤷ Sign Up

Patent: 64833
Patent: Composition pharmaceutique stabilisée à la lumière (Photostabilized pharmaceutical composition)
Estimated Expiration: ⤷ Sign Up

Georgia, Republic of

Patent: 0146122
Patent: PHARMACEUTICAL COMPOSITION
Estimated Expiration: ⤷ Sign Up

Patent: 0146166
Patent: PHARMACEUTICAL COMPOSITION
Estimated Expiration: ⤷ Sign Up

Japan

Patent: 95356
Estimated Expiration: ⤷ Sign Up

Patent: 93363
Estimated Expiration: ⤷ Sign Up

Patent: 11529445
Estimated Expiration: ⤷ Sign Up

Patent: 13047239
Patent: PHARMACEUTICAL COMPOSITION
Estimated Expiration: ⤷ Sign Up

Malaysia

Patent: 6305
Patent: PHARMACEUTICAL COMPOSITION
Estimated Expiration: ⤷ Sign Up

Patent: 9461
Patent: PHARMACEUTICAL COMPOSITION
Estimated Expiration: ⤷ Sign Up

Mexico

Patent: 11000757
Patent: COMPOSICION FARMACEUTICA. (PHARMACEUTICAL COMPOSITION.)
Estimated Expiration: ⤷ Sign Up

Morocco

Patent: 556
Patent: تركيب صيدلاني
Estimated Expiration: ⤷ Sign Up

New Zealand

Patent: 1344
Patent: Stabilized pharmaceutical composition comprising a nonpeptidic active agent
Estimated Expiration: ⤷ Sign Up

Patent: 2592
Patent: Light irradiation resistant pharmaceutical composition
Estimated Expiration: ⤷ Sign Up

Peru

Patent: 110591
Patent: COMPOSICION FARMACEUTICA ESTABILIZADA A BASE DE UN COMPUESTO NO PEPTIDICO
Estimated Expiration: ⤷ Sign Up

Patent: 140977
Patent: COMPOSICION FARMACEUTICA ESTABILIZADA A BASE DE UN COMPUESTO NO PEPTIDICO
Estimated Expiration: ⤷ Sign Up

Patent: 141585
Patent: COMPOSICION FARMACEUTICA ESTABILIZADA A BASE DE UN COMPUESTO NO PETIDICO
Estimated Expiration: ⤷ Sign Up

Singapore

Patent: 6685
Patent: PHARMACEUTICAL COMPOSITION
Estimated Expiration: ⤷ Sign Up

South Africa

Patent: 1101198
Patent: PHARMACEUTICAL COMPOSITION
Estimated Expiration: ⤷ Sign Up

South Korea

Patent: 110042334
Patent: PHARMACEUTICAL COMPOSITION
Estimated Expiration: ⤷ Sign Up

Spain

Patent: 60962
Estimated Expiration: ⤷ Sign Up

Patent: 69592
Estimated Expiration: ⤷ Sign Up

Taiwan

Patent: 1010992
Patent: Pharmaceutical composition
Estimated Expiration: ⤷ Sign Up

Patent: 1431552
Patent: Pharmaceutical composition
Estimated Expiration: ⤷ Sign Up

Tunisia

Patent: 11000030
Patent: PHARACEUTICAL COMPOSITION
Estimated Expiration: ⤷ Sign Up

Ukraine

Patent: 3332
Patent: ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, КОТОРАЯ СОДЕРЖИТ НЕПЕПТИДНЫЙ АКТИВНЫЙ АГЕНТ С ПЕРВИЧНОЙ ИЛИ ВТОРИЧНОЙ АМИНОГРУППОЙ;ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО МІСТИТЬ НЕПЕПТИДНИЙ АКТИВНИЙ АГЕНТ З ПЕРВИННОЮ АБО ВТОРИННОЮ АМІНОГРУПОЮ (PHARMACEUTICAL COMPOSITION CONTAINING A NONPEPTIDIC ACTIVE AGENT HAVING A PRIMARY OR SECONDARY AMINO GROUP)
Estimated Expiration: ⤷ Sign Up

Uruguay

Patent: 008
Patent: COMPOSICIÓN FARMACÉUTICA
Estimated Expiration: ⤷ Sign Up

Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.

See the table below for additional patents covering VOQUEZNA TRIPLE PAK around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Poland	2327692		⤷ Sign Up
Spain	2669592		⤷ Sign Up
Spain	2391757		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration